A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation. Issue 17 (2nd August 2021)

• Record Type: Journal Article
• Authors: Seiler, Lisa K.; Jonczyk, Rebecca; Lindner, Patrick; Phung, Ncog Linh; Falk, Christine S.; Kaufeld, Jessica; Gwinner, Wilfried; Scheffner, Irina; Immenschuh, Stephan; Blume, Cornelia
• Is Part Of: Analyst. Volume 146:Issue 17(2021)
• Page Start: 5369
• Page End: 5379
• Publication Date: 2021-08-02
• Subjects: Chemistry, Analytic -- Periodicals; 543
• DOI: 10.1039/d1an01001h
• Languages: English
• ISSNs: 0003-2654

Abstract

Abstract : In this work a novel point of care test to detect sIL-2R during acute kidney rejection with high specificity and sensitivity was developed. Abstract : Kidney is the most frequently transplanted among all solid organs worldwide. Kidney transplant recipients (KTRs) undergo regular follow-up examinations for the early detection of acute rejections. The gold standard for proving a T-cell mediated rejection (TCMR) is a biopsy of the renal graft often occurring as indication biopsy, in parallel to an increased serum creatinine that may indicate deterioration of renal transplant function. The goal of the current work was to establish a lateral flow assay (LFA) for diagnosing acute TCMR to avoid harmful, invasive biopsies. Soluble interleukin-2 (IL-2) receptor (sIl-2R) is a potential biomarker representing the α-subunit of the IL-2 receptor produced by activated T-cells, e.g., after allogen contact. To explore the diagnostic potential of sIL-2R as a biomarker for TCMR and borderline TCMR, plasma and urine samples were collected from three independent KTR cohorts with various distinct histopathological diagnostic findings according to BANFF (containing 112 rsp. 71 rsp. 61 KTRs). Samples were analyzed by a Luminex-based multiplex technique and cut off-ranges were determined. An LFA was established with two specific sIL-2R-antibodies immobilized on a nitrocellulose membrane. A significant association between TCMR, borderline TCMR and sIL-2R in plasma and between TCMR and sIL-2R in urine of KTRs was confirmed using the Mann–Whitney U test. The LFA was tested with sIL-2R-spiked buffer samples establishing a detection limit of 25 pM. The performance of the new LFA was confirmed by analyzing urine samples of the 2 nd and 3 rd patient cohort with 35 KTRs with biopsy proven TCMRs, 3 KTRs diagnosed with borderline TCMR, 1 mixed AMR/TCMR rsp. AMR/borderline TCMR and 13 control patients with a rejection-free kidney graft proven by protocol biopsies. The new point-of-care assay showed a specificity of 84.6% and sensitivity of 87.5%, and a superior estimated glomerular filtration rate (eGFR) at the time point of biopsy (specificity 30.8%, sensitivity 85%).